Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025Frontiers in OncologyOpen Access

Research progress of molecular typing and targeted therapy for triple-negative breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

DXDongxi XiangXYXin Yue

Discussion

Loading...

Member takes

Overview

Systematic review highlights breakthroughs in molecular typing and targeted therapy for TNBC, suggesting new treatment strategies.

Key Points

  • Significant advancements in molecular typing have improved the understanding of triple-negative breast cancer.
  • New targeted therapy strategies show promise in addressing the issues of drug resistance and poor prognosis.
  • Chemotherapy remains a primary treatment but is limited by heterogeneity and high recurrence rates.
  • Continued research in genomics is essential for developing specific targets for TNBC therapies.

Cite This Study

Xiang et al. (2025) studied this question.

synapsesocial.com/papers/68c23caeb210217d64789e0dhttps://doi.org/10.3389/fonc.2025.1666126
View Full Paper
Ask AI
Bookmark
Share